The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 11, 2019
Filed:
Jul. 06, 2016
Sanofi, Paris, FR;
Carsten Corvey, Frankfurt am Main, DE;
Heike Stump, Frankfurt am Main, DE;
Jochen Kruip, Frankfurt am Main, DE;
Christian Lange, Frankfurt am Main, DE;
Ingo Focken, Frankfurt am Main, DE;
Dorothea Rat, Frankfurt am Main, DE;
Thomas Stuedemann, Frankfurt am Main, DE;
Hans-Falk Rasser, Frankfurt am Main, DE;
Juergen Schaefer, Frankfurt am Main, DE;
Bernard Calandra, Paris, FR;
Astrid Rey, Paris, FR;
Michael Mourez, Paris, FR;
Laurent Fraisse, Paris, FR;
Christine Rothe, Freising, DE;
Andrea Allersdorfer, Freising, DE;
Alexander Wiedenmann, Herbrechtingen, DE;
Marlon Hinner, Freising, DE;
Bradley Lunde, Lebanon, NH (US);
Kristian Jensen, Landshut, DE;
Martin Hülsmeyer, Römerberg, DE;
SANOFI, Paris, FR;
Abstract
The present invention relates to fusion molecules that have binding specificity for pyoverdine type I, II and III and pyochelin and can be used in various applications, including diagnostic and/or therapeutic applications, for example, to inhibit or reduce growth ofand/or to prevent or treatbiofilm infection as well as diseases or disorders associated withbiofilm infection. The present invention also concerns methods of producing the fusion molecules described herein as well as compositions and kits comprising such fusion molecules. The present invention further relates to nucleic acid molecules encoding the fusion molecules described herein.